Cardiovascular Devices Market Research Reports & Industry Analysis
The global cardiovascular devices market is expected to grow at a robust pace in the coming years. This market encompasses a wide range of products, from cardiovascular monitoring and diagnostic devices to surgery devices. A variety of well-known companies compete in this market including Abbott Laboratories, Boston Scientific, and Medtronic, among others. Gain an in-depth understanding of the cardiovascular devices market with the reports available on MarketResearch.com.
Cutting-Edge Cardiovascular Devices Market Data
- Find the latest market intelligence covering cardiovascular devices market trends, forecasts, and the competitive landscape.
- Discover valuable insights related to growth opportunities, regional comparisons, and new product development.
- Save time with our convenient platform, featuring reports from hundreds of research firms all in one place.
MarketResearch.com: A Name You Can Trust
For over two decades, MarketResearch.com has stood at the forefront of the industry, serving top investment banks, life science companies, management consulting firms, and universities. Our extensive collection of research is coupled with unparalleled customer service. When you need assistance, our knowledgeable team of research specialists is ready to guide you in finding the research that matches your specific requirements. Explore our current cardiovascular device market research reports today.
Cardiovascular Devices Industry Research & Market Reports
-
Tissue Heart Valves
... at a CAGR of 2.4% over the analysis period 2024-2030. Stented Valves, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.3 Billion by the end of ... Read More
-
ECG Cable and ECG Lead Wires
... reach US$2.6 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Thermoplastic Elastomer, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices
... reach US$37.9 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Holter Monitoring Systems
... at a CAGR of 6.5% over the analysis period 2024-2030. Holter Monitoring Devices, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$414.3 Million by the end ... Read More
-
Heart Rate Monitors
... at a CAGR of 10.6% over the analysis period 2024-2030. Chestband, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$778.6 Million by the end of the ... Read More
-
Cardiovascular Surgery Devices
... at a CAGR of 3.5% over the analysis period 2024-2030. Perfusion Disposables, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Percutaneous Coronary Intervention (PCI) Devices
... Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.4 Billion ... Read More
-
Heart Valve Repair and Replacement Devices
... reach US$43.1 Billion by 2030, growing at a CAGR of 16.0% over the analysis period 2024-2030. Replacement Devices, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach ... Read More
-
Heart Pump Devices
... at a CAGR of 17.4% over the analysis period 2024-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$5.1 Billion by the ... Read More
-
Cardiac Rehabilitation Devices
... at a CAGR of 4.8% over the analysis period 2024-2030. Treadmill, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Cardiac monitoring & cardiac rhythm management devices
... expected to reach US$38.2 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Electrocardiogram (ECG) Devices, one of the segments analyzed in the report, is expected to record a 3.8% ... Read More
-
Cardiovascular Disease Monitoring and Diagnostic Devices
... reach US$3.6 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. ECG Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach ... Read More
-
Aortic Endografts
... CAGR of 3.7% over the analysis period 2024-2030. Abdominal Aortic Grafts, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Cardiac Rhythm Management (CRM) Devices
... Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$11.3 Billion by ... Read More
-
Cardiac Pacemakers
... CAGR of 3.0% over the analysis period 2024-2030. Implantable Pacemaker Devices, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Interventional Cardiology Devices
... at a CAGR of 6.7% over the analysis period 2024-2030. Angioplasty Balloons, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$7.3 Billion by the end of ... Read More
-
Prosthetic Heart Valves
... at a CAGR of 7.6% over the analysis period 2024-2030. Transcatheter Heart Valves, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$7.2 Billion by the end ... Read More
-
Patient Monitoring Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Blood Glucose, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 Billion by the end of ... Read More
-
Embolotherapy
... 7.7% over the analysis period 2024-2030. Embolic Agents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth ... Read More
-
Cardiac Mapping
... CAGR of 7.8% over the analysis period 2024-2030. Atrial Fibrillation, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Transcatheter Heart Valves
... at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the ... Read More
-
ECG Telemetry Devices
... at a CAGR of 4.4% over the analysis period 2024-2030. Resting ECG Devices, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.2 Billion by the end ... Read More
-
Sacral Nerve Stimulation (SNS) Devices
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Implantable, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$2.2 Billion by ... Read More
-
Cardiovascular Information Systems
... at a CAGR of 6.1% over the analysis period 2024-2030. Catheterization Lab CVIS Solutions, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$844.6 Million by the ... Read More
-
Cardiac Ablation
... CAGR of 10.7% over the analysis period 2024-2030. Cardiac Rhythm Management, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$1.8 Billion by the end of the ... Read More
Research Assistance
